Oncolytic VSV expressing soluble Flt3L was generated to increase the number of DCs and promote tumour antigen presentation in VSV-resistant B16 melanoma and VSV-sensitive E.G7 T lymphoma models [50]. Here, FLT3LG is linked to melanoma.